Pure Extracts Technologies (CNSX:PULL) - Aandelenkoers, Nieuws & Analyse

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

PULL Overzicht aandelen

Engages in the extraction and processing of cannabis and hemp to produce oils and various derivative products in Canada.

Over het bedrijf

PULL fundamentele analyse
Sneeuwvlok Score
Waardering	0/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	0/6
Dividenden	0/6

Beloningen

De omzet groeide het afgelopen jaar met 157.2%

Risicoanalyse

Heeft geen betekenisvolle marktkapitalisatie ( CA$1M )

Aandelen zijn zeer illiquide

Negatief eigen vermogen

De laatste financiële rapporten zijn meer dan een jaar oud

+ 1 meer risico

Pure Extracts Technologies Corp. Concurrenten

RAMM Pharma

CNSX:RAMM

CA$1.2m

Lophos Holdings

CNSX:MESC

CA$858.6k

SOL Global Investments

CNSX:SOL

CA$1.9m

SugarBud Craft Growers

TSXV:SUGR.H

CA$718.6k

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Pure Extracts Technologies
Historische aandelenkoersen
Huidige aandelenkoers	CA$0
52 Week Hoogtepunt	CA$0
52 Week Laag	CA$0
Bèta	2.07
11 maand verandering	n/a
3 maanden verandering	n/a
1 Jaar Verandering	n/a
33 jaar verandering	n/a
5 jaar verandering	n/a
Verandering sinds IPO	n/a

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	PULL	CA Pharmaceuticals	CA Markt
7D	n/a	3.6%	1.4%
1Y	n/a	9.8%	27.4%

Rendement versus industrie: Er zijn onvoldoende gegevens om te bepalen hoe PULL presteerde ten opzichte van de Canadian Pharmaceuticals.

Rendement versus markt: Er zijn onvoldoende gegevens om te bepalen hoe PULL presteerde ten opzichte van de Canadian markt.

Prijsvolatiliteit

Is PULL's price volatile compared to industry and market?
PULL volatility
PULL Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.1%
Market Average Movement	8.2%
10% most volatile stocks in CA Market	17.3%
10% least volatile stocks in CA Market	3.0%

Stabiele aandelenkoers: PULL heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: Onvoldoende gegevens om de volatiliteitsverandering van PULL in het afgelopen jaar te bepalen.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
n/a	n/a	Ben Nikolaevsky	pureextractscorp.com

Pure Extracts Technologies Corp. Samenvatting

Hoe verhouden de winst en inkomsten van Pure Extracts Technologies zich tot de beurswaarde?
PULL fundamentele statistieken
Marktkapitalisatie	CA$1.17m
Inkomsten(TTM)	-CA$4.00m
Inkomsten(TTM)	CA$2.44m

0.0x

P/S-verhouding

0.0x

Koers/Winstverhouding

Is PULL overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
PULL resultatenrekening (TTM)
Inkomsten	CA$2.44m
Kosten van inkomsten	CA$2.68m
Brutowinst	-CA$244.59k
Overige uitgaven	CA$3.75m
Inkomsten	-CA$4.00m

Laatst gerapporteerde inkomsten

Mar 31, 2023

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.034
Brutomarge	-10.03%
Nettowinstmarge	-163.85%
Schuld/Eigen Vermogen Verhouding	-568.7%

Hoe presteerde PULL op de lange termijn?

Bekijk historische prestaties en vergelijking

PULL Overzicht aandelen

Beloningen

Risicoanalyse

Pure Extracts Technologies Corp. Concurrenten

CNSX:RAMM

CA$1.2m

CNSX:MESC

CA$858.6k

CNSX:SOL

CA$1.9m

TSXV:SUGR.H

CA$718.6k

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Pure Extracts Technologies Corp. Announces Board and Secretary Changes

Pure Extracts Technologies Corp. Announces Resignation of Yana Popova as Chief Financial Officer

Second quarter 2023 earnings released: CA$0.009 loss per share (vs CA$0.01 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.008 loss per share (vs CA$0.014 loss in 1Q 2022)

Pure Extracts Receives Approval from Manitoba Liquor & Lotteries to List Pure Pulls Vapes and Pure Chews Edibles

Less than half of directors are independent

Recent updates

Pure Extracts Technologies Corp. Announces Board and Secretary Changes

Pure Extracts Technologies Corp. Announces Resignation of Yana Popova as Chief Financial Officer

Second quarter 2023 earnings released: CA$0.009 loss per share (vs CA$0.01 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.008 loss per share (vs CA$0.014 loss in 1Q 2022)

Pure Extracts Receives Approval from Manitoba Liquor & Lotteries to List Pure Pulls Vapes and Pure Chews Edibles

Less than half of directors are independent

Less than half of directors are independent

Pure Extracts Technologies Corp. announced that it has received CAD 0.445275 million in funding

Founder recently sold CA$51k worth of stock

Pure Extracts Commences Production of 1 Gram FSO Vape Cartridges in Preparation for Retail Distribution and Revenue

CEO & Director recently sold CA$63k worth of stock

Pure Extracts Technologies Corp. Sells First Shipment of Cannabis Oil Extracts to German Pharma Company

Pure Extracts Technologies Corp. and ShroomBloom Labs Sign Psychedelic Mushroom Supply Letter of Intent

Pure Extracts Technologies Corp. Submits Dealer’s Licence Application to Health Canada

Pure Extracts Submits Application to Health Canada for Sales License

Pure Extracts Technologies Corp. Submits Multiple SKUs to Health Canada for Approval

Pure Extracts Technologies Corp. and Canada House Wellness Group Sign Agreement to Distribute Concentrate Products Through Existing Provincial Distribution Channels

New 90-day high: CA$0.81

Pure Extracts Agrees to Licensing Deal with Taste-T, LLC for Fireball Cannabis Gummies

Pure Extracts Technologies Corp. Announces its First Commercial Sale of CBD Oil on the Wholesale Market

Pure Extracts Enters into Biomass Purchase Agreements to Support Oil Extract Production

Pure Extracts Technologies Corp. announced that it has received CAD 8.534633 million in funding

Pure Extracts Technologies Corp. Delineates Study on Psilocybin Oral Tablets, Capsules and Nasal Gel

Pure Extracts Commences Study on Psilocybin Oral Tablets, Capsules and Nasal Gel

Pure Extracts Technologies Corp. Commences Build-Out of Facility in Preparation for Mushroom Extraction and Dealer's Licence

Pure Extracts Applauds Health Canada SAP for Psilocybin-Assisted Psychotherapy Inclusion

Pure Extracts Collaborates with Dr. Alexander Macgregor on Cannabis and Mushroom Formulations

Pure Extracts Technologies Common Shares to Be Deleted from Other OTC

Pure Extracts Technologies Corp. Advances Plans for the Processing of Functional Mushroom Formulations

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

Pure Extracts Technologies Corp. Samenvatting

0.0x

0.0x

Inkomsten en omzet